DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-3.39%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.78B
AUM Growth
+$2.78B
(+6.6%)
Cap. Flow
+$268M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
39.18%
Holding
111
New
16
Increased
25
Reduced
19
Closed
12
Top Buys
| 1 |
Viatris
VTRS
|
$81.2M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$42.1M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$38.4M |
| 4 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$37.1M |
| 5 |
STAAR Surgical
STAA
|
$25.8M |
Top Sells
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$90.8M |
| 2 |
Centene
CNC
|
$19.1M |
| 3 |
Glaukos
GKOS
|
$17.9M |
| 4 |
Axogen
AXGN
|
$17.3M |
| 5 |
Ascendis Pharma
ASND
|
$17M |
Sector Composition
| 1 | Healthcare | 67.78% |
| 2 | Financials | 0.96% |
| 3 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
26
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $27.3M | 0.98% |
264,600
+12,400
| +5% | +$1.28M |
|
27
Xeris Biopharma Holdings
XERS
$1.27B
| $27.2M | 0.98% |
2,379,901
+24,765
| +1% | +$283K |
|
28
KalVista Pharmaceuticals
KALV
$713M
| $27M | 0.97% |
1,217,668
+567,668
| +87% | +$12.6M |
|
29
eHealth
EHTH
$126M
| $26.8M | 0.96% |
310,900
-128,709
| -29% | -$11.1M |
|
|
DBVT
30
DBV Technologies
DBVT
$249M
| $26.3M | 0.95% |
320,122
+150,000
| +88% | +$12.3M |
|
|
DFBHU
31
DELISTED
DFB Healthcare Acquisitions Corp. Unit
DFBHU
| $25.9M | 0.93% |
2,500,000
| – | – |
|
|
32
STAAR Surgical
STAA
$1.35B
| $25.8M | 0.93% |
+876,512
| New | +$25.8M |
|
|
NVRO
33
DELISTED
NEVRO CORP.
NVRO
| $25M | 0.9% |
386,000
-193,463
| -33% | -$12.5M |
|
|
SILK
34
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $24.2M | 0.87% |
+499,030
| New | +$24.2M |
|
35
BioCryst Pharmaceuticals
BCRX
$1.74B
| $23.9M | 0.86% |
6,292,980
-244,586
| -4% | -$927K |
|
|
NVTA
36
DELISTED
Invitae Corporation
NVTA
| $23.4M | 0.84% |
995,312
+582,112
| +141% | +$13.7M |
|
37
Molina Healthcare
MOH
$9.6B
| $21.5M | 0.77% |
150,000
+64,000
| +74% | +$9.16M |
|
38
PTC Therapeutics
PTCT
$4.41B
| $21.2M | 0.76% |
471,000
+234,000
| +99% | +$10.5M |
|
39
Arvinas
ARVN
$580M
| $20.3M | 0.73% |
921,234
| – | – |
|
40
Addus HomeCare
ADUS
$2.08B
| $19M | 0.68% |
252,915
| – | – |
|
|
BOLD
41
DELISTED
Audentes Therapeutics, Inc
BOLD
| $18.7M | 0.67% |
493,901
| – | – |
|
|
RETA
42
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $18.6M | 0.67% |
197,000
-167,000
| -46% | -$15.8M |
|
|
SWAV
43
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $17.8M | 0.64% |
312,146
| – | – |
|
44
Humana
HUM
$37.5B
| $17.8M | 0.64% |
+67,000
| New | +$17.8M |
|
45
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $17.7M | 0.64% |
1,310,259
| – | – |
|
|
46
Axogen
AXGN
$718M
| $17.6M | 0.63% |
891,306
-875,700
| -50% | -$17.3M |
|
47
Wave Life Sciences
WVE
$1.27B
| $17.5M | 0.63% |
669,260
+274,523
| +70% | +$7.16M |
|
48
Rocket Pharmaceuticals
RCKT
$358M
| $17.1M | 0.61% |
1,137,142
+857,142
| +306% | +$12.9M |
|
|
49
Centene
CNC
$14.8B
| $15.9M | 0.57% |
303,000
-364,000
| -55% | -$19.1M |
|
50
Elevance Health
ELV
$72.4B
| $15M | 0.54% |
53,000
| – | – |
|